Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

Urinary cytokines after HCT: evidence for renal inflammation in the pathogenesis of proteinuria and kidney disease

Abstract

We compared urinary levels of cytokines in patients with and without albuminuria, proteinuria and kidney disease (glomerular filtration rate<60 mL/min per 1.73 m2) after HCT. Plasma and urine were collected at baseline and weekly through day 100 and monthly through year 1, for measurement of IL-6, gp130, sIL6r, IL-10, IL15, MCP-1 and urine albumin-to-creatinine ratios (ACRs). Cox-proportional hazards modeling examined associations between urinary cytokine levels and development of these renal end points. The association of ACR with the hazard of overall mortality was assessed using Cox regression. Increasing urinary IL-6 and IL-15 were associated with an increased risk of developing proteinuria. Urinary MCP-1 during the first 100 days post HCT was associated with kidney disease at 1 year. The degree of albuminuria at any time point in the first 100 days post transplant was related to the subsequent risk of death (for ACR 30–299, hazard ratio (HR)=1.91; 95% confidence interval (CI): 1.27–2.87; for ACR >300, HR=2.82; 95% CI: 1.60–4.98). After HCT, elevated urinary levels of pro-inflammatory cytokines are associated with development of albuminuria and proteinuria, suggesting early intra-renal inflammation as an important pathogenetic mechanism. Albuminuria and proteinuria within the first 100 days post HCT are associated with decreased overall survival.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Cohen EP, Lawton CA, Moulder JE . Bone marrow transplant nephropathy: radiation nephritis revisited. Nephron 1995; 70: 217–222.

    Article  CAS  Google Scholar 

  2. Hingorani S, Guthrie KA, Schoch G, Weiss NS, McDonald GB . Chronic kidney disease in long-term survivors of hematopoietic cell transplant. Bone Marrow Transplant 2007; 39: 223–229.

    Article  CAS  Google Scholar 

  3. Weiss AS, Sandmaier BM, Storer B, Storb R, McSweeney PA, Parikh CR . Chronic kidney disease following non-myeloablative hematopoietic cell transplantation. Am J Transplant 2006; 6: 89–94.

    Article  CAS  Google Scholar 

  4. Guinan EC, Tarbell NJ, Niemeyer CM, Sallan SE, Weinstein HJ . Intravascular hemolysis and renal insufficiency after bone marrow transplantation. Blood 1988; 72: 451–455.

    CAS  PubMed  Google Scholar 

  5. Cohen EP, Piering WF, Kabler-Babbitt C, Moulder JE . End-stage renal disease (ESRD) after bone marrow transplantation: poor survival compared to other causes of ESRD. Nephron 1998; 79: 408–412.

    Article  CAS  Google Scholar 

  6. Carella AM, Champlin R, Slavin S, McSweeney P, Storb R . Mini-allografts: ongoing trials in humans. Bone Marrow Transplant 2000; 25: 345–350.

    Article  CAS  Google Scholar 

  7. Doroshow JHaS TW . Pharmacologic basis for high-dose chemotherapy. In: Appelbaum FR, Blume KG, Forman SJ, Negrin RS (eds). Thomas' Hematopoietic Cell Transplantation, 4th edn. Wiley-Blackwell: Malden, UK, 2009 pp 289–315.

    Google Scholar 

  8. Leather HL, Wingard JR . Bacterial infections. In: Appelbaum FR, Blume KG, Forman SJ, Negrin RS (eds). Thomas' Hematopoietic Cell Transplantation 4th edn. Wiley-Blackwell: Malden, UK, 2009 pp 1325–1345.

    Chapter  Google Scholar 

  9. Zaia JA . Cytomegalovirus infections. In: Appelbaum FR, Blume KG, Forman SJ, Negrin RS (eds). Thomas' Hematopoietic Cell Transplantation, 4th edn. Wiley-Blackwell: Malden, UK, 2009 pp 1367–1381.

    Chapter  Google Scholar 

  10. Brown JMY . Fungal infections after hematopoietic cell transplantation. In: Appelbaum FR, Blume KG, Forman SJ, Negrin RS (eds). Thomas' Hematopoietic Cell Transplantation, Wiley-Blackwell: Malden, UK, 2009 pp 1346–1366.

    Chapter  Google Scholar 

  11. Brown JWMY . Fungal infections after hematopoietic cell transplantation. In: Appelbaum FR, Blume KG, Forman SJ, Negrin RS (eds). Thomas' Hematopoietic Cell Transplantation, 4th edn. Wiley-Blackwell: Malden, UK, 2009 pp 1346–1366.

    Chapter  Google Scholar 

  12. Ito J . Herpes simplex virus infections. In: Appelbaum FR, Blume KG, Forman SJ, Negrin RS (eds). Thomas' Hematopoietic Cell Transplantation, 4th edn. Wiley-Blackwell: Malden, UK, 2009 pp 1382–1387.

    Chapter  Google Scholar 

  13. Ho DY, Arvin AM . Varicella-zoster virus infections. In: Appelbaum FR, Blume KG, Forman SJ, Negrin RS (eds). Thomas' Hematopoietic Cell Transplantation, Wiley-Blackwell: Malden, UK, 2009 pp 1388–1409.

    Chapter  Google Scholar 

  14. Ruutu T, Eriksson B, Remes K, Juvonen E, Volin L, Remberger M et al. Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. Blood 2002; 100: 1977–1983.

    Article  CAS  Google Scholar 

  15. Edward J Roccella for National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114: 555–576.

    Article  Google Scholar 

  16. Kishimoto T . IL-6: from its discovery to clinical applications. Int Immunol 2010; 22: 347–352.

    Article  CAS  Google Scholar 

  17. Harada K, Akai Y, Kurumatani N, Iwano M, Saito Y . Prognostic value of urinary interleukin 6 in patients with IgA nephropathy: an 8-year follow-up study. Nephron 2002; 92: 824–826.

    Article  CAS  Google Scholar 

  18. Wolkow PP, Niewczas MA, Perkins B, Ficociello LH, Lipinski B, Warram JH et al. Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics. J Am Soc Nephrol 2008; 19: 789–797.

    Article  CAS  Google Scholar 

  19. Fehniger TA, Caligiuri MA . Interleukin 15: biology and relevance to human disease. Blood 2001; 97: 14–32.

    Article  CAS  Google Scholar 

  20. Shinozaki M, Hirahashi J, Lebedeva T, Liew FY, Salant DJ, Maron R et al. IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis. J Clin Investig 2002; 109: 951–960.

    Article  CAS  Google Scholar 

  21. Weiler M, Rogashev B, Einbinder T, Hausmann MJ, Kaneti J, Chaimovitz C et al. Interleukin-15, a leukocyte activator and growth factor, is produced by cortical tubular epithelial cells. J Am Soc Nephrol 1998; 9: 1194–1201.

    CAS  PubMed  Google Scholar 

  22. Zager RA, Johnson AC, Becker K . Acute unilateral ischemic renal injury induces progressive renal inflammation, lipid accumulation, histone modification, and “end-stage” kidney disease. Am J Physiol Renal Physiol 2011; 301: F1334–F1345.

    Article  CAS  Google Scholar 

  23. Munshi R, Johnson A, Siew ED, Ikizler TA, Ware LB, Wurfel MM et al. MCP-1 gene activation marks acute kidney injury. J Am Soc Nephrol 2011; 22: 165–175.

    Article  CAS  Google Scholar 

  24. Wada T, Furuichi K, Sakai N, Iwata Y, Yoshimoto K, Shimizu M et al. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int 2000; 58: 1492–1499.

    Article  CAS  Google Scholar 

  25. Couriel D, Caldera H, Champlin R, Komanduri K . Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. Cancer 2004; 101: 1936–1946.

    Article  Google Scholar 

  26. Krenger W, Hill GR, Ferrara JL . Cytokine cascades in acute graft-versus-host disease. Transplantation 1997; 64: 553–558.

    Article  CAS  Google Scholar 

  27. Takatsuka H, Takemoto Y, Okamoto T, Fujimori Y, Tamura S, Wada H et al. Thrombotic microangiopathy following allogeneic bone marrow transplantation. Bone Marrow Transplant 1999; 24: 303–306.

    Article  CAS  Google Scholar 

  28. Seconi J, Watt V, Ritchie DS . Nephrotic syndrome following allogeneic stem cell transplantation associated with increased production of TNF-alpha and interferon-gamma by donor T cells. Bone Marrow Transplant 2003; 32: 447–450.

    Article  CAS  Google Scholar 

  29. Teshima T, Ordemann R, Reddy P, Gagin S, Liu C, Cooke KR et al. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med 2002; 8: 575–581.

    Article  CAS  Google Scholar 

  30. Hingorani SR, Seidel K, Lindner A, Aneja T, Schoch G, McDonald G . Albuminuria in hematopoietic cell transplantation patients: prevalence, clinical associations, and impact on survival. Biol Blood Marrow Transplant 2008; 14: 1365–1372.

    Article  Google Scholar 

Download references

Acknowledgements

This research was supported by the National Institutes of Health (NIDDK) 1R01DK080860-01. Chronic kidney disease in survivors of hematopoietic cell transplant received by Dr Hingorani.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S Hingorani.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hingorani, S., Gooley, T., Pao, E. et al. Urinary cytokines after HCT: evidence for renal inflammation in the pathogenesis of proteinuria and kidney disease. Bone Marrow Transplant 49, 403–409 (2014). https://doi.org/10.1038/bmt.2013.197

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2013.197

Keywords

This article is cited by

Search

Quick links